This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Multilateral task force seeks public comment on updating approaches to pharma mergers

( May 11, 2021, 15:30 GMT | Official Statement) -- MLex Summary: Competition law enforcers from multiple jurisdictions are seeking public comment on their review of how to best update their approaches to analyzing the effects of pharmaceutical mergers. A notice seeking comments was issued by staff from US Federal Trade Commission, the European Commission's competition directorate, the UK Competition and Markets Authority, the US Department of Justice’s Antitrust Division, and offices of state attorneys general. The Task Force, initiated by the FTC, seeks to identify concrete and actionable steps to update the analysis of pharmaceutical mergers. The public comment may be followed by a public workshop.Document is attached and separate statements from the DOJ and FTC follow...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login